Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment.

about

Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment.

Item

http://www.wikidata.org/entity/Q46125868

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@en

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@nl

type

Item

label

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@en

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@nl

prefLabel

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@en

Pharmacokinetic evaluation of ...... ort early efficacy assessment.

@nl

P1476

Pharmacokinetic evaluation of ...... port early efficacy assessment

@en

P2093

Chad J Warren

http://www.w3.org/2001/XMLSchema#string

Jan L Wahlstrom

http://www.w3.org/2001/XMLSchema#string

Lesley A Albin

http://www.w3.org/2001/XMLSchema#string

Mark E Smith

http://www.w3.org/2001/XMLSchema#string

Po-Chang Chiang

http://www.w3.org/2001/XMLSchema#string

Sarbani Ghosh

http://www.w3.org/2001/XMLSchema#string

Steve P Wene

http://www.w3.org/2001/XMLSchema#string

P2860

Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway

Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Drug screening--beyond the bottleneck.

Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension

Kidney CYP450 enzymes: biological actions beyond drug metabolism.

Nanosuspensions in drug delivery.

The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.

Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.

P304

291-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11671-007-9063-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven L Roberds

P577

2007-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

3246351

http://www.w3.org/2001/XMLSchema#string